April 2010 Briefing - DermatologyLast Updated: May 03, 2010.
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for April 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Risk Factors for Physician Misconduct Identified
WEDNESDAY, April 28 (HealthDay News) -- Doctors who are male, are from lower socioeconomic groups or had academic difficulties in medical school may be at increased risk of professional misconduct, according to a study published online April 27 in BMJ.
FDA Changes Medical Device Advisory Committee Process
TUESDAY, April 27 (HealthDay News) -- Because of the increasing number of medical device advisory panel meetings in recent years, the U.S. Food and Drug Administration is changing the way expert panels review and discuss information during public hearings on devices that are being reviewed for premarket approval.
Financial Ties Negatively Affect Perceptions of Research Quality
TUESDAY, April 27 (HealthDay News) -- Disclosure of financial ties to industry influences patients', physicians', and research participants' beliefs about the quality of research evidence, according to a review published in the April 26 issue of the Archives of Internal Medicine.
T. Tonsurans Rate High in Black Children in Kansas City
THURSDAY, April 22 (HealthDay News) -- Of Kansas City schoolchildren tested for Trichophyton tonsurans infection, 6.6 percent exhibited positive cultures, and black children had the highest prevalence of infection, according to a study published online April 19 in Pediatrics.
Susceptibility Loci Identified for Generalized Vitiligo
WEDNESDAY, April 21 (HealthDay News) -- There are associations between generalized vitiligo and markers implicating multiple genes, including some associated with other autoimmune diseases and one -- TYR -- that may mediate target-cell specificity and indicate a mutually exclusive relationship between susceptibility to vitiligo and susceptibility to melanoma, according to a study published online April 21 in the New England Journal of Medicine.
E-visits for Acne Patient Follow-Up Found Effective
WEDNESDAY, April 21 (HealthDay News) -- Follow-up care for acne patients delivered via online visits, or "e-visits," results in an equivalent outcome clinically compared with conventional office visits, according to a study in the April issue of the Archives of Dermatology.
Shared Appointments Improve Census, Profit in Dermatology
TUESDAY, April 20 (HealthDay News) -- In dermatology practices, shared medical appointments (SMAs) can increase patient access and productivity and be financially profitable, according to research published in the April issue of the Archives of Dermatology.
Indoor Tanning Addiction Observed in College Students
TUESDAY, April 20 (HealthDay News) -- Many college students meet the criteria for addiction to indoor tanning, which is also associated with an increased likelihood of anxiety and substance use, according to a study published in the April issue of the Archives of Dermatology.
Autoantibodies of Little Prognostic Value in Melanoma
THURSDAY, April 15 (HealthDay News) -- In melanoma patients who are treated with adjuvant pegylated interferon alfa-2b, the appearance of autoimmune antibodies is not a prognostic or predictive factor for improved outcome, according to research published online April 12 in the Journal of Clinical Oncology.
Newly Found Gene Implicated in Hair Loss Condition
THURSDAY, April 15 (HealthDay News) -- Researchers have discovered a genetic mutation that appears to be involved in hair loss in people with hereditary hypotrichosis simplex and perhaps other hair loss conditions, according to research published in the April 15 issue of Nature.
Accelerated Radiotherapy Has Potential for Poor Countries
WEDNESDAY, April 14 (HealthDay News) -- Accelerated fractionation of radiotherapy is an effective alternative to conventional fractionation for squamous-cell carcinoma of the head and neck (HNSCC) in developing countries, according to research published online April 9 in The Lancet Oncology.
FDA Updates Web Site With Triclosan Information
THURSDAY, April 8 (HealthDay News) -- The U.S. Food and Drug Administration has updated its Web site (www.fda.gov) with information about triclosan, a common ingredient used in many consumer products -- including antibacterial soaps and body washes, toothpastes, and some cosmetics -- to reduce or prevent bacterial contamination.
Recurrence Unlikely for Many Biopsied Melanocytic Nevi
MONDAY, April 5 (HealthDay News) -- In patients who undergo biopsy of benign to moderately dysplastic melanocytic nevi, there is a low rate of clinical recurrence, so re-excision may not be necessary, according to a study in the April issue of the Journal of the American Academy of Dermatology.
Changes in Photoallergic Contact Dermatitis Identified
MONDAY, April 5 (HealthDay News) -- Over the past 20 years, sunscreens and antimicrobial agents have been the most frequent allergens causing photoallergic contact dermatitis (PACD), while the number of reactions to medications has increased and PACD caused by fragrances has decreased, according to research published in the April issue of the Journal of the American Academy of Dermatology.
Short-Course Imiquimod Found Effective on Full Face, Scalp
FRIDAY, April 2 (HealthDay News) -- In patients with actinic keratoses, a short-course regimen of imiquimod 2.5 or 3.75 percent may be an effective treatment for the balding scalp or full face, according to research published in the April issue of the Journal of the American Academy of Dermatology.
MEDI-545 Found Acceptably Safe in Chronic Psoriasis
THURSDAY, April 1 (HealthDay News) -- MEDI-545 -- a fully human anti-interferon-α monoclonal antibody -- appears safe in patients with chronic plaque psoriasis but does not significantly inhibit the type I interferon gene signature in these patients, suggesting that interferon-α (IFN-α) doesn't play a significant role in maintaining the disease, according to research published in the March issue of the Journal of the American Academy of Dermatology.